CDSCO panel asks Cipla to include more Govt sites in Budesonide, Formoterol FDC study Medical Dialogues Team25 Nov 2021 6:02 PM ISTNew Delhi: Recommending to include more government sites, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Sun Pharma Dapagliflozin, Glimepiride, Metformin FDC gets CDSCO panel nod for phase 3 trial Medical Dialogues Team24 Nov 2021 6:28 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel allows Novartis to waiver conditions for study of anti malarial drug Cipargamin Medical Dialogues Team23 Nov 2021 5:59 PM ISTNew Delhi: Based on the justification provided by the pharma major Novartis, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC Medical Dialogues Team22 Nov 2021 5:34 PM ISTNew Delhi: Approving the waiver of the phase 3 clinical trial, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Novartis gets CDSCO panel nod to study Dabrafenib, Trametinib FDC Medical Dialogues Team21 Nov 2021 11:45 AM ISTNew Delhi: In a significant development, pharma major Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the Central...
Patent Infringement: GSK moves court against Glenmark over Vilor F Medical Dialogues Team20 Nov 2021 4:51 PM ISTNew Delhi: Coming down on Glenmark Pharmaceuticals, British drug maker GlaxoSmithKline has filed a patent infringement case in the Delhi High Court...
CDSCO panel rejects Synokem Pharma proposal for oral antidiabetic drug Imeglimin Medical Dialogues Team19 Nov 2021 8:14 PM ISTNew Delhi: Rejecting the drug major Synokem Pharma's proposal for oral anti-diabetic medication Imeglimin 500mg and 1000mg Tab, the Subject Expert...
Novartis gets CDSCO panel nod to conduct phase 3 study of anti-cancer drug Asciminib Medical Dialogues Team18 Nov 2021 4:25 PM ISTNew Delhi: In a significant development, major drug-maker Novartis has got a go ahead from the Subject Expert Committee (SEC) functional under the...
Glenmark gets CDSCO panel nod to market Remogliflozin, Teneligliptin, Metformin FDC drug Medical Dialogues Team17 Nov 2021 4:59 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial and bioequivalence study waver, the Subject Expert Committee (SEC) of the Central...
Cadila gets CDSCO panel nod to manufacture, market Calcium Polystyrene Sulphonate suspension Medical Dialogues Team16 Nov 2021 6:57 PM ISTNew Delhi: Pharmaceutical major Cadila Healthcare has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs...
IPC releases list of new impurities, Indian Pharmacopoeial Reference standards, Details Medical Dialogues Team15 Nov 2021 5:41 PM ISTNew Delhi: Through recently issued notice the Indian Pharmacopoeia Commission (IPC) has added 7 new Indian Pharmacopoeial Reference standards and 23...
36 drug samples fail to qualify CDSCO test Farhat Nasim14 Nov 2021 5:25 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 36...
